Impact News +++ Cancom erfüllt Prognose mit 102,5 Millionen EBITDA (4investors) +++ CANCOM Aktie -4,73%

INSPIRE MEDICAL Aktie

>INSPIRE MEDICAL Aktienkurs

53.12 EUR -7.3% (TradegateBSX)

Ask: 51.52 EUR / 70 Stück

Bid: 50.6 EUR / 70 Stück

Tagesumsatz: 129 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>INSPIRE MEDICAL Performance

1 Woche: -0,5%

1 Monat: -33,6%

3 Monate: -26,9%

6 Monate: -17,8%

1 Jahr: -67,9%

laufendes Jahr: -29,2%

>INSPIRE MEDICAL Aktie

Name:

INSPIRE MEDICAL SYSTEMS

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US4577301090 / A2JLEP

Symbol/ Ticker:

2DR (Frankfurt) / INSP (NYSE)

Kürzel:

FRA:2DR, ETR:2DR, 2DR:GR, NYSE:INSP

Index:

Webseite:

https://www.inspiresleep...

Profil:

Inspire Medical Systems, Inc. is a pioneering comp..
>Volltext..

Marktkapitalisierung:

1619.67 Mio. EUR

Unternehmenswert:

1372.22 Mio. EUR

Umsatz:

741.73 Mio. EUR

EBITDA:

41.46 Mio. EUR

Nettogewinn:

37.44 Mio. EUR

Gewinn je Aktie:

1.26 EUR

Schulden:

27.38 Mio. EUR

Liquide Mittel:

94.83 Mio. EUR

Operativer Cashflow:

112.35 Mio. EUR

Bargeldquote:

2.91

Umsatzwachstum:

10.84%

Gewinnwachstum:

27.92%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

INSPIRE MEDICAL

Letzte Datenerhebung:

12.02.26

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 29.06 Mio. St.

Frei handelbar: 95.52%

Leerverk. Aktien: 13.31%

Rückkaufquote: 9.69%

Mitarbeiter: 1246

Umsatz/Mitarb.: 0.54 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 79.54%

Bewertung:

KGV: 47.73

KGV lG: 46.18

KUV: 2.25

KBV: 3.03

PEG-Ratio: 1.3

EV/EBITDA: 33.09

Rentabilität:

Bruttomarge: 84.92%

Gewinnmarge: 5.05%

Operative Marge: 4.16%

Managementeffizenz:

Gesamtkaprendite: 5.56%

Eigenkaprendite: 6.54%

>Peer Group

Gesundheit

>INSPIRE MEDICAL Chart & Kurs - NYSE

>INSPIRE MEDICAL News

12.02.26 - 03:39	Inspire Medical Systems signals 2026 revenue outlook of $950M-$1B amid coding changes and reimbursement headwinds (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.02.26 - 01:00	Inspire Medical (INSP) Q4 2025 Earnings Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

12.02.26 - 01:00	Inspire Medical Systems (INSP) Beats Q4 Earnings and Revenue Estimates (Zacks)
	Inspire (INSP) delivered earnings and revenue surprises of +137.65% and +0.03%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...

12.02.26 - 00:42	Inspire Medical Systems übertrifft Gewinnprognosen für Q4 2025 deutlich (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

11.02.26 - 23:24	Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.02.26 - 22:12	Inspire Medical Systems Non-GAAP EPS of $1.65 beats by $0.97, revenue of $269.1M beats by $2.88M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.02.26 - 22:06	Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire EN)
	Launch of Inspire V system complete with strong revenue and profitability performance in the fourth quarter and FDA approval for 3.0T MRI compatibility Launch of Inspire V system complete with strong revenue and profitability performance in the fourth quarter and FDA approval for 3.0T MRI compatibility...

04.02.26 - 17:30	Inspire Medical Systems (INSP) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
	Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

30.01.26 - 20:03	Kuehn Law Encourages Investors of Inspire Medical Systems, Inc. to Contact Law Firm (PR Newswire)
	NEW YORK, Jan. 30, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inspire Medical Systems, Inc. (NYSE: INSP) breached their fiduciary duties to shareholders. According to a federal securities lawsuit,......

22.01.26 - 20:48	Inspire Medical-Aktie bricht ein: US-Behörde streicht Kostenerstattung für Schlafapnoe-Therapie/n (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

13.01.26 - 02:01	Insiderhandel: Vorstand verkauft Aktien von Inspire Medical Systems im Wert von 10900 USD (Insiderkauf)
	Rondoni, John - Vorstand - Tag der Transaktion: 2026-01-09...

12.01.26 - 13:00	Inspire Medical Systems announces Q4 and FY25 guidance, appoints new CFO (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.01.26 - 12:48	Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance (GlobeNewswire EN)
	Inspire Announces Appointment of Matt Osberg as Executive Vice President and Chief Financial Officer Joining the Company in the First Quarter of 2026 Inspire Announces Appointment of Matt Osberg as Executive Vice President and Chief Financial Officer Joining the Company in the First Quarter of 2026...

07.01.26 - 14:03

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 (GlobeNewswire EN)

MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading on Wednesday, February 11. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments....

04.01.26 - 14:30	Faruqi & Faruqi LLP: SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 (Newsfile)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their OptionsIf you purchased ......

03.01.26 - 15:03	2-DAY DEADLINE ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut (PR Newswire)
	Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline SAN FRANCISCO, Jan. 3, 2026 /PRNewswire/ -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical......

03.01.26 - 12:30	Bleichmar Fonti & Auld: INSP DEADLINE MONDAY: BFA Law Reminds Inspire Medical Systems, Inc. Investors with Losses to Contact BFA Law About the Securities Fraud Class Action Before Monday′s Deadline (Newsfile)
	New York, New York--(Newsfile Corp. - January 3, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire M......

02.01.26 - 15:03	Investors in Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP (PR Newswire)
	NEW YORK, Jan. 2, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc." or the "Company") (NYSE: INSP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Inspire......

01.01.26 - 15:03	5-DAY DEADLINE ALERT: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut (PR Newswire)
	Partner Reed Kathrein Urges Investors to Contact Firm Before January 5, 2026 Lead Plaintiff Deadline SAN FRANCISCO, Jan. 1, 2026 /PRNewswire/ -- National investor rights law firm Hagens Berman alerts INSP investors to the pending securities class action lawsuit against Inspire Medical......

01.01.26 - 14:54	SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026 (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Mag alles Leid und Schatten sein - doch diese süße Sonnenstunde nicht, und nicht der Duft vom roten Klee, und nicht das tiefe, zarte Wohlgefühl in meiner Seele. - Hermann Hesse

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram